IT1274249B - Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine - Google Patents

Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine

Info

Publication number
IT1274249B
IT1274249B ITMI950224A ITMI950224A IT1274249B IT 1274249 B IT1274249 B IT 1274249B IT MI950224 A ITMI950224 A IT MI950224A IT MI950224 A ITMI950224 A IT MI950224A IT 1274249 B IT1274249 B IT 1274249B
Authority
IT
Italy
Prior art keywords
lysine
sodium
pharmaceutical formulations
cysteine salt
formulations based
Prior art date
Application number
ITMI950224A
Other languages
Italian (it)
Inventor
Maria Concetta Dragani
Luigi Boltri
Marco Gentile
Gaetano Clavenna
Original Assignee
Dompe Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Spa filed Critical Dompe Spa
Priority to ITMI950224A priority Critical patent/IT1274249B/en
Publication of ITMI950224A0 publication Critical patent/ITMI950224A0/en
Publication of ITMI950224A1 publication Critical patent/ITMI950224A1/en
Application granted granted Critical
Publication of IT1274249B publication Critical patent/IT1274249B/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Oral formulation based on a carboxymethyl cysteine salt of lysine, containing at least two sweetening agents selected from two of the following three classes respectively: a) sorbitol, glucose, saccharose, purified honey, hydrogenated glucose syrup, isomalt, mannitol, lactose and maltose, b) fructose, xylitol, invert sugar and aspartame c) ammonium glycirrhyzinate, saccharine, sodium saccharinate, calcium saccharinate, sodium cyclamate and glycirrhysic acid, together with sodium carboxymethyl cellulose as a viscosity-imparting agent.
ITMI950224A 1995-02-08 1995-02-08 Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine IT1274249B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ITMI950224A IT1274249B (en) 1995-02-08 1995-02-08 Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI950224A IT1274249B (en) 1995-02-08 1995-02-08 Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine

Publications (3)

Publication Number Publication Date
ITMI950224A0 ITMI950224A0 (en) 1995-02-08
ITMI950224A1 ITMI950224A1 (en) 1996-08-08
IT1274249B true IT1274249B (en) 1997-07-15

Family

ID=11370467

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI950224A IT1274249B (en) 1995-02-08 1995-02-08 Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine

Country Status (1)

Country Link
IT (1) IT1274249B (en)

Also Published As

Publication number Publication date
ITMI950224A0 (en) 1995-02-08
ITMI950224A1 (en) 1996-08-08

Similar Documents

Publication Publication Date Title
CA2246730A1 (en) Confections containing sweetener
HUP0400932A2 (en) Pharmaceutical composition containing nateglinide and another antidiabetic compound, process for its preparation and for use the same
BR9713226A (en) Chewing gum containing a sweetener
CA2014569A1 (en) Orally administered pharmaceutical composition for use in gastrointestinal washes, in particular for diagnostic use, or as cathartic laxative
CA2213719A1 (en) Transparent rapid-release preparation of non-steroid analgesics
SE8702941L (en) PHARMACEUTICAL, N-ACETYL-CYSTEIN-CONTAINING, WATER-SOLUBLE COMPOSITION
PT929234E (en) TABLETS CONTAINING A SWEETENER
GB2210545B (en) Sucralose compositions
GR3020228T3 (en) Chewable tablet containing sucralfate
NO20005332L (en) 1,6-GPS (6-O-α-D-glucopyranosyl-D-sorbit) and 1,1-GPM (1-O-α-D-glucopyranosyl-D-mannite) -containing sugar alcohol composition for use as therapeutic active substance as well as drug containing said composition
IT1274249B (en) Pharmaceutical formulations based on a carboxymethyl cysteine salt of lysine
CA2244357A1 (en) A novel pharmaceutical composition for inhalation containing cr 2039 (andolast)
DE59510583D1 (en) PHARMACEUTICAL COMPOSITION FOR SYSTEMIC TRANSDERMAL ADMINISTRATION WITH THE ACTIVE MORPHINE-6-GLUCURONIDE
ATE79253T1 (en) XYLIT AND SUGAR FREE CHEWABLE TABLET.
CA2022323A1 (en) Excretion of potassium ion by prostanoic acid derivatives
EP0356254A3 (en) Pharmaceutical formulations
JPS57208943A (en) Sterilization of cuttlefishes
BE903975A (en) FORMULATIONS FREE OF SUCROSIS.

Legal Events

Date Code Title Description
0001 Granted